Oral Drug Delivery Videos
-
Bolstering Bowel And Bladder Control With Dignify Therapeutics' Karl Thor
2/6/2025
In this episode of Sit and Deliver, host Tom von Gunden talks with Chief Scientific Officer Karl Thor of Dignify Therapeutics about providing relief for patients suffering from neurogenic bowel and bladder dysfunction.
-
Minitabs Technology
8/29/2024
Discover a multiparticulate system that provides unparalleled flexibility in dosage forms, which allows you to create customized release profiles, precise dosing, and a wide range of delivery options.
-
Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load
8/13/2024
Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.
-
Oral Solid Dosage Technology
8/29/2024
Discover how Parvulet's unique formulation simplifies medication administration for patients of all ages, especially those with swallowing difficulties.
-
PBPK Modeling: Mitigating Absorption Risks In Early Drug Development
Discover how PBPK models combined with in vitro tools and solubility enhancement expertise can be used to identify and mitigate absorption risks in early drug development.
-
Scaling Up A Revolutionary Amorphous Solid Dispersion Platform
3/19/2024
Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.
-
An EDDO Identification Tutorial For An On-Body Injector (OBI)
4/23/2025
In this segment of the Drug Delivery Leader Live event EDDOs Revisited: Putting Essential Drug Delivery Outputs Into Practice, consultant Susan Neadle of Combination Products Consulting Services, LLC, and Alan Stevens, regulatory head of complex devices and drug delivery systems at AbbVie, use a hypothetical case study for an on-body injector (OBI) to demonstrate a template for identifying EDDOs.
-
Drug Delivery Market Success: Lessons From A Discontinued Product
5/23/2025
In this segment of the Drug Delivery Leader Live online event, Innovations In Drug Delivery: Opportunities For Enhancing Familiar, Mature Approaches, host Fran DeGrazio and James Wabby, head of global regulatory affairs for emerging device technologies and combination products at AbbVie, ponder the discontinuation of Repatha® Pushtronex®. They comment on how its withdrawal may illustrate key market drivers and factors that bolster a product’s success or, alternatively, lead to its demise.
-
Partnering On Patient Needs With DSM-Firmenich's George Mihov And Lukasz Koroniak
10/23/2024
Principal Scientist George Mihov and Global Biomaterials Director Lukasz Koroniak from DSM-Firmenich join Supplier Horizons host Tom von Gunden to discuss partnering with pharma on formulation development. Among the topics covered are translational research, materials development, and complex molecules required for biologic-based therapies.
-
Formulations, Devices, Regulations, and Patients: Two Takes On Drug Delivery Trends
3/14/2025
In this unique episode of In Combination, series host Tom von Gunden, Chief Editor at Drug Delivery Leader, puts himself in combination with DDL Executive Editor Fran DeGrazio as the two share perspectives on drug delivery trends.